<DOC>
	<DOCNO>NCT00640848</DOCNO>
	<brief_summary>The aim study determine minimum effective dose ACT-078573 sleep efficiency assess effect different dos ACT-078573 PSG parameter .</brief_summary>
	<brief_title>Almorexant Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Men woman 18 65 year age ( inclusive ) . Women childbearing potential must negative urine pregnancy test screen visit , screen adaptation night , pretreatment use reliable method contraception entire study duration least 3 month study drug intake . Reliable method contraception : Barrier type device ( e.g. , female condom , diaphragm , contraceptive sponge ) combination spermicide . Intrauterine device . Oral , injectable , implantable transdermal contraceptive combination barrier method . Abstention , rhythm method , contraception partner alone acceptable method contraception . Women childbearing potential defined prepubescent , postmenopausal ( i.e. , amenorrhea least 1 year ) , surgically naturally sterile . Body mass index ( BMI ) 18 30 kg/m2 ( limit include ) screen visit . 12lead ECG without clinically relevant abnormality screen visit . Hematology biochemistry test result deviate normal range clinically relevant extent screen visit follow screening/adaptation night . Primary insomnia DSMIVTR criterion base medical history assessment perform screen visit . History follow least 3 month prior screen visit : Usual report subjective total sleep time ( TST ) 3 6 hour . Usual sleep disturbance subjective sleep onset latency &gt; 30 min . Daytime complaint associate poor sleep ( e.g. , fatigue , irritability , difficulty concentrate ) . Polysomnography ( PSG ) screening/adaptation night confirm TST &lt; 6 h LPS ≥ 20 min . Willingness refrain CNSactive drug 5 halflives respective drug ( least 1 week ) prior screening/adaptation night end treatment period 2 . The usage shortacting hypnotic ( define hypnotic halflife include 10 hour ) allow 48 hour prior PSG night , i.e. , prior screening/adaptation night prior treatment PSG night . Urine drug test negative barbiturate , cannabinoids , amphetamine , cocaine screen visit 1 , screening/adaptation PSG night pretreatment . Urine drug test negative benzodiazepine opiates screening/adaptation PSG night pretreatment . Signed informed consent prior studymandated procedure . Symptom assessment questionnaire ( SBB ) diagnosis apnea result score &gt; 2 screen visit . Zung selfrating depression scale ( SDS ) and/or Zung selfrating anxiety scale ( SAS ) result raw score ≥ 50 screen visit . Restless legs syndrome and/or meeting four essential diagnostic criterion RLS ( see Appendix 10 ) . Insomnia due sleep apnea periodic limb movement disorder assess PSG screening/adaptation night : apnea/hypopnea index ( AHI ) &gt; 10/h periodic limb movement arousal index &gt; 10/h Major depressive disorder , severe psychosis , significant anxiety disorder . Pregnancy breastfeed . Systolic blood pressure &gt; 160 mmHg and/or diastolic blood pressure &gt; 100 mmHg screen visit . Within 2month period prior screen visit , clinical evidence alcoholism drug abuse . Any known factor disease might interfere treatment compliance , study conduct interpretation result psychiatric disease disease may affect pharmacokinetics study drug . Treatment strong inhibitor CYP3A4 ( e.g. , azole derivative , ritonavir , clarithromycin ) within 1 week prior screening/adaptation PSG night end treatment period 2 . Excessive caffeine consumption ( regular caffeine consumption &gt; 7 unit per day ) . Night shift worker . Known hypersensitivity excipients drug formulation . Planned treatment treatment another investigational drug within 1 month prior randomization end treatment period 2 . Known concomitant lifethreatening disease life expectancy &lt; 24 month . Unstable medical abnormality , significant medical disorder acute illness . Recruitment patient twice dose level . Patients may recruit low dose level , provide least 28 day last study drug administration screening/adaptation PSG night .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>